PALI
PALISADE BIO, INC.
+0.05 (+2.66%)1.74USD2.3M成交股數302M市值2.7本益比(近四季)604.7股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 500K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | – | 0.00 | 0.00 |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 6.0M | 6.0M | 6.2M | 1.4M | 1.7M | 950K | 16.0M | 2.6M | 2.2M | 362K | 2.1M | 2.2M |
| 銷售管理費用 | 4.8M | 4.4M | 3.8M | 1.5M | 1.2M | 1.4M | 1.5M | 1.6M | 1.5M | – | 1.7M | 1.4M |
| 營業利益 | −11.7M+311% | −10.7M+365% | −10.0M+178% | −2.9M-31% | −2.8M-23% | −2.3M | −3.6M-5% | −4.2M+17% | −3.7M | – | −3.8M | −3.6M |
| 營業利益率 | -2,339.6% | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −10.6M+280% | −9.6M+330% | −8.9M+155% | −2.9M-30% | −2.8M-21% | −2.2M | −3.5M-3% | −4.1M+20% | −3.5M | – | −3.6M | −3.4M |
| 淨利率 | -2,114.8% | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.05-91% | -0.05-89% | 1.13-149% | -0.38-89% | -0.58-87% | -0.47 | -2.32-69% | -3.32-58% | -4.59 | – | -7.38 | -7.93 |
| 稀釋股數 | 211M | 210M | 55.7M | 7.5M | 4.8M | 4.8M | 1.5M | 1.2M | 768K | – | 490K | 428K |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 125M | 133M | 133M | 5.2M | 5.4M | 7.2M | 8.0M | 11.4M | 11.3M | 12.4M | 15.3M | 16.4M |
| 應收帳款 | 500K | – | 0.00 | – | 0.00 | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 127M | 133M | 134M | 7.0M | 6.7M | 8.2M | 9.3M | 12.9M | 12.7M | 14.1M | 17.1M | 18.3M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 5.6M | 6.0M | 5.0M | 3.8M | 4.0M | 2.9M | 2.7M | 2.9M | 2.6M | 2.7M | 3.0M | 2.5M |
| 股東權益 | 122M | 127M | 129M | 3.2M | 2.6M | 5.3M | 6.6M | 9.9M | 10.1M | 11.3M | 14.1M | 15.8M |
| 負債比 | 4.4% | 4.5% | 3.7% | 53.9% | 60.7% | 34.9% | 29.2% | 22.7% | 20.5% | 19.5% | 17.5% | 13.6% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −3.9M+67% | – | – | – | −2.3M | – | – | −3.2M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 0.00 | – | −16.8M | –% | -0.30 | – |
| FY2024 | 0.00 | -100.0% | −14.4M | –% | -10.19 | −12.2M |
| FY2023 | 250K | – | −12.3M | -4,920.0% | -27.01 | −11.1M |
| FY2022 | 0.00 | – | −14.3M | –% | -16.53 | −13.4M |
| FY2021 | – | – | −26.6M | –% | -169.74 | −14.8M |
| FY2020 | 14K | -12.2% | −10.3M | -76,346.2% | -3.72 | −4.8M |
| FY2019 | 15K | -94.1% | −8.4M | -54,252.6% | -3.80 | – |
| FY2018 | 260K | – | −4.9M | -1,894.1% | -7.54 | −7.7M |